Triptans other than sumatriptan in child and adolescent migraine: Literature review

Expert Review of Neurotherapeutics

Volumn 11, Issue 3, 2011, Pages 395-401

  Vollono, Catello ^a   Vigevano, Federico ^a   Tarantino, Samuela ^a   Valeriani, Massimiliano ^a,b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

zolmitriptan

Indexed keywords

ALMOTRIPTAN; ANALGESIC AGENT; ANTIEMETIC AGENT; ELETRIPTAN; IBUPROFEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIZATRIPTAN; SEDATIVE AGENT; SUMATRIPTAN; ZOLMITRIPTAN;

ADOLESCENCE; ADOLESCENT DISEASE; ANALGESIA; ASTHENIA; BURNING SENSATION; CHILD; CHILDHOOD DISEASE; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GASTROINTESTINAL SYMPTOM; HOT FLUSH; HUMAN; JAW DISEASE; JOINT STIFFNESS; MEDLINE; MIGRAINE; MIGRAINE AURA; MUSCLE RIGIDITY; NAUSEA; NOSE CONGESTION; NOSE DISEASE; PAIN; PARESTHESIA; PATIENT SATISFACTION; PHONOPHOBIA; PHOTOPHOBIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOMNOLENCE; SYNCOPE; SYSTEMATIC REVIEW; TASTE DISORDER; UNSPECIFIED SIDE EFFECT; VOMITING; XEROSTOMIA;

ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 79952692181     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.147     Document Type: Review

References (48)

1. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 309, 765-769 (1994)
2. Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia 12, 238-243 (1992)
3. Barea LM, Tannhauser M, Rotta NT. An epidemiologic study of headache among children and adolescents of southern Brazil. Cephalalgia 16, 545-549 (1996)
4. Metsähonkala L, Sillanpää M, Tuominen J. Use of health care services in childhood migraine. Headache 36, 423-428 (1996)
5. Winner P, Wasiewski W, Gladstein J, Linder S. Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Pediatric Headache Committee of the American Association for the Study of Headache. Headache 37, 545-548 (1997)
6. Degrauw TJ, Hershey AD, Powers SW, Bentti AL. Diagnosis of migraine in children attending a pediatric headache clinic. Headache 39, 481-485 (1999)
7. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia 24(Suppl. 1), 24-36 (2004)
8. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl. 7), 1-96 (1988)
9. Landy S. Migraine throughout the life cycle: treatment through the ages. Neurology 62(Suppl. 2), S2-S8 (2004)
10. 1B/1D agonists) in acute migraine treatment - a meta-analysis of 53 trials. Lancet 358, 1668-1675 (2001)
11. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N. Engl. J. Med. 346, 257-270 (2002)
12. Dowson AJ, Mathew NT, Pascual J. Review of clinical trials using early acute intervention with oral triptans for migraine management. Int. J. Clin. Pract. 60, 698-706 (2006)
13. Evers S, Afra J, Frese A et al.; European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur. J. Neurol. 16, 968-981 (2009)
14. Johnston MM, Rapoport AM. Triptans for the management of migraine. Drugs 70, 1505-1518 (2010)
15. Goadsby PJ. Serotonin receptor ligands: treatments of acute migraine and cluster headache. Handb. Exp. Pharmacol. 177, 129-143 (2007)
16. Bulloch B, Tenenbein M. Emergency department management of pediatric migraine. Pediatr. Emerg. Care 16, 196-201 (2000)
17. Hamalainen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology 48, 1100-1103 (1997)
18. Winner P, Rothner AD, Saper J et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 106, 989-997 (2000)
19. Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 46, 212-222 (2006)
20. Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 62, 883-887 (2004)
21. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 52, 1507-1510 (1999)
22. Hershey AD, Powers SW, LeCates S, Bentti AL. Effectiveness of nasal sumatriptan in 5- to 12-year-old children. Headache 41, 693-697 (2001)
23. Rothner AD, Winner P, Nett R et al. One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study. Clin. Ther. 22, 1533-1546 (2000)
24. Natarajan S, Jabbour JT, Webster CJ, Richardson MS. Longterm tolerability of sumatriptan nasal spray in adolescent patients with migraine. Headache 44, 969-977 (2004)
25. Pakalnis A, Kring D, Paolicchi J. Parental satisfaction with sumatriptan nasal spray in childhood migraine. J. Child Neurol. 18, 772-775 (2003)
26. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practise. Headache 36, 419-422 (1996)
27. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 34, 581-582 (1994)
28. Loder E, Goldstein R, Biondi D. Placebo effects in oral triptan trials: the scientific and ethical rational for continued use of placebo controls. Cephalalgia 25, 124-131 (2005)
29. Fernandes R, Ferreira JJ, Sampaio C. The placebo response in studies of acute migraine. J. Pediatr. 152, 527-533 (2008)
30. McAlhany A. Efficacy of sumatriptan in the treatment of migraine: a review of the literature. J. Neurosci. Nurs. 33, 270-277, 285 (2001)
31. Hämäläinen M, Jones M, Loftus J, Saiers J. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger. Int. J. Clin. Pract. 56, 704-709 (2002)
32. Major PW, Grubisa HS, Thie NM. Triptans for treatment of acute pediatric migraine: a systematic literature review. Pediatr. Neurol. 29, 425-429 (2003)
33. Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 120, 390-396 (2007)
34. Evers S, Rahmann A, Kraemer C et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 67, 497-499 (2006)
35. Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J. Zolmitriptan oral tablet in migraine treatment: high placebo response in adolescents. Headache 46, 101-109 (2006)
36. 1B/1D agonist. International clinical experience based on >3000 subjects treated with zolmitriptan. Cephalalgia 17(Suppl. 18), 41-52 (1997)
37. Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int. J. Clin. Pract. 54, 466-469 (2000)
38. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 42, 49-55 (2002)
39. Visser WH, Winner P, Strohmaier K et al.; Rizatriptan Protocol 059 and 061 Study Groups. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache 44, 891-899 (2004)
40. Ahonen K, Hämäläinen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology 67, 1135-1140 (2006)
41. Charles JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. J. Headache Pain 7, 95-97 (2006)
42. Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 48, 1326-1336 (2008)
43. Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache 47, 511-518 (2007)
44. Christensen ML, Eades SK, Fuseau E, Kempsford RD, Phelps SJ, Hak LJ. Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. J. Clin. Pharmacol. 41, 170-175 (2001)
45. Elkind AH, Wade A, Ishkanian G. Pharmacokinetics of frovatriptan in adolescent migraineurs. J. Clin. Pharmacol. 44, 1158-1165 (2004)
46. Rothner A, Edwards K, Kerr L, DeBussey S, Asgharnejhad M. Efficacy and safety of naratriptan tablets in adolescent migraine. J. Neurol. Sci. 150(Suppl. 1), S106 (1997)
47. Winner P, Powers SW, Kabbouche MA, Hershey AD. Diagnosing and managing headache in children. Curr. Treat. Options Neurol. 9, 3-13 (2007)
48. Vollono C, Capuano A, Mei D et al. Multiple attack study on the available triptans in Italy versus placebo. Eur. J. Neurol. 12, 557-563 (2004)